Repare Therapeutics Inc (RPTX)
3.54
+0.02
(+0.57%)
USD |
NASDAQ |
Jun 21, 16:00
Repare Therapeutics Total Liabilities (Quarterly): 31.13M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 31.13M |
| December 31, 2023 | 41.82M |
| September 30, 2023 | 53.04M |
| June 30, 2023 | 56.17M |
| March 31, 2023 | 85.06M |
| December 31, 2022 | 84.56M |
| September 30, 2022 | 103.38M |
| June 30, 2022 | 82.53M |
| March 31, 2022 | 78.49M |
| Date | Value |
|---|---|
| December 31, 2021 | 80.29M |
| September 30, 2021 | 77.39M |
| June 30, 2021 | 75.56M |
| March 31, 2021 | 71.42M |
| December 31, 2020 | 70.26M |
| September 30, 2020 | 69.44M |
| June 30, 2020 | 68.08M |
| March 31, 2020 | 151.70M |
| December 31, 2019 | 148.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
31.13M
Minimum
Mar 2024
151.70M
Maximum
Mar 2020
79.40M
Average
76.48M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| InMed Pharmaceuticals Inc | 2.254M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 263.08M |
| Shareholders Equity (Quarterly) | 231.95M |
| Current Ratio | 8.331 |